Morgans AM - Thursday, 26 March 2026

from Morgans Financial Limited · host Morgans Financial

US equity markets advanced amid hopes of a ceasefire in the US-Iran war - Dow +305-points or +0.66%. Sherwin-Williams Co (+2.63%) and Merck & Co Inc (+2.58%) climbing over >2.5%. The latter announced that it will acquire US biotech firm Terns Pharmaceuticals for US$53 per share in cash, valuing the company at ~US$6.7B. Terns is developing TERN-701, an oral therapy for chronic myeloid leukemia. It marks Merck’s third multibillion-dollar acquisition in the past year as the company looks to strengthen its portfolio ahead of its top-selling cancer drug Keytruda losing patent protection in 2028.

Episode metadata supplied by the publisher feed · Published Mar 25, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Morgans AM - Thursday, 26 March 2026

0:00 5:38

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Morgans Financial Limited?

This episode is 5 minutes long.

When was this Morgans Financial Limited episode published?

This episode was published on March 25, 2026.

Can I download this Morgans Financial Limited episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!